A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.
Clinical trial NCT03540524 · COMPLETED
Trial details
- NCT number
- NCT03540524
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2019-03-11
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.